Tandem Diabetes Care (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

Fintel reports that on April 10, 2025, Mizuho initiated coverage of Tandem Diabetes Care (NasdaqGM:TNDM) with a Neutral ...

Mizuho initiated coverage of Tandem Diabetes (TNDM) with a Neutral rating and $20 price target The firm’s neutral stance reflects both the ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $35.11, a high ...

Some stocks are lagging the market for good reasons -- because their businesses look shaky and their prospects uncertain.

In this episode of Vanguards of Health Care, Sheridan sits down with BI analyst Matt Henriksson for an in-depth interview about Tandem’s Mobi pump, designed for discretion and simplicity, and the ...

slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq ... Control-IQ+, compatible with both the t:slim X2 insulin pump and Tandem Mobi System, is now available for people with type ...

Tandem Diabetes Care, Inc. TNDM shares soared 7.6% in the ... the company’s reported sales grew by a staggering 44%, while worldwide pump shipments increased by more than 25%.

CMO Jordan Pinsker said Tandem hopes to expand Medicare coverage of its automated insulin delivery systems with results of a ...